Fingerprint
Dive into the research topics of 'Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically